# A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers

> **NCT02799121** · PHASE4 · COMPLETED · sponsor: **Avita Medical** · enrollment: 16 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** ReGenerCell™ Autologous Cell Harvesting Device

## Key facts

- **NCT ID:** NCT02799121
- **Lead sponsor:** Avita Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-03-29
- **Final completion:** 2019-03-29
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799121, "A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02799121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*